Drug Patents Give Companies Like GlaxoSmithKline Incentive to Lie
|
|
|
Thursday, 15 July 2010 22:10 |
|
A NYT editorial commented on evidence that the drug maker GlaxoSmithKline had concealed negative research findings on its diabetes drug Avandia:
"The clearest lesson to emerge from the hearings and other recent revelations is that GlaxoSmithKline, the maker of Avandia, can’t be trusted to report adverse clinical results fairly. The company must be watched like a hawk as additional trials that it sponsors go forward."
Arghhhhhhhhhhhhhhhh! Doesn't the NYT believe in the profit motive and incentives? The patent system, by granting monopolies that raise prices several thousand percent above the cost of production, gives drug companies an enormous incentive to conceal negative research findings. As long as these perverse incentives exist, then we have to watch every drug company like a hawk.
Maybe some wacko socialists think that drug companies will act for the public good and willingly forego vast profits, but those who believe on markets and economics know that drug companies will try to get away with anything they can get away with. One day maybe an iota of original thought will be allowed into public policy debates on the patent system, but we haven't gotten there yet.
(Only one link allowed per comment)
 |
Socialists would gladly aid in the takedown of a corporation that traded product safety for profits if any of our "leaders" had the gumption to give it a try. Trouble is, there aren't any gutsy leaders and not nearly enough Socialists to make it happen.
There aren't even enough honest journalists to inform the public of the patent scams the drug companies use to put patients' lives in danger.